NTRB

Nutriband Inc. (NASDAQ:NTRB) is a biotechnology company founded in 2016 and headquartered in Orlando, Florida. The company went public in October 2021 and specializes in developing transdermal pharmaceutical products, with a primary focus on abuse-deterrent drug delivery systems. Nutriband's core mission centers on creating safer alternatives to traditional pharmaceutical formulations, particularly for controlled substances like opioids that carry high abuse potential. The company operates as a development-stage biotechnology firm, working to advance its pipeline of transdermal patches and related drug delivery technologies through clinical trials and regulatory approval processes.